CXCR4 and Myocardial fibrosis: Conversely, another group reported that systemic O/E of miR-150 in mice by AgomiR injection reduced myocardial fibrosis and protected their hearts from acute MI through decreasing monocyte migration via targeting CXCR4 [25].